The molecular interaction of estrogen receptor (ER) and progesterone receptor (PR) signaling in hormone-receptor-positive breast cancer results in a modulatory effect of PR on the action of ER to attenuate tumor growth via multiple pathways. The gene discussed is PGR; the disease is neoplasm.